The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?

Wen Juei Jeng; Grace Lai Hung Wong

doi:10.1097/HC9.0000000000000060

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?

Wen Juei Jeng
, Grace Lai Hung Wong^*

^*Corresponding author for this work

School of Medicine

Chinese University of Hong Kong

Research output: Contribution to journal › Journal Editorial

1 Scopus citations

Original language	English
Article number	e0060
Pages (from-to)	e0060
Journal	Hepatology Communications
Volume	7
Issue number	3
DOIs	https://doi.org/10.1097/HC9.0000000000000060
State	Published - 02 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/HC9.0000000000000060

Cite this

@article{906ddc23e7754110b86e64fdde04b25f,

title = "The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?",

author = "Jeng, \{Wen Juei\} and Wong, \{Grace Lai Hung\}",

year = "2023",

month = feb,

doi = "10.1097/HC9.0000000000000060",

language = "英语",

volume = "7",

pages = "e0060",

journal = "Hepatology Communications",

issn = "2471-254X",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - The truth of the matter

T2 - will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?

AU - Jeng, Wen Juei

AU - Wong, Grace Lai Hung

PY - 2023/2

Y1 - 2023/2

UR - https://www.scopus.com/pages/publications/85206463588

U2 - 10.1097/HC9.0000000000000060

DO - 10.1097/HC9.0000000000000060

M3 - 社论

C2 - 36790353

AN - SCOPUS:85206463588

SN - 2471-254X

VL - 7

SP - e0060

JO - Hepatology Communications

JF - Hepatology Communications

IS - 3

M1 - e0060

ER -

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?

UN SDGs

Access to Document

Other files and links

Cite this